Search research articles
Contact Us
Filters
Showing results (31-40 of 118) with videos related to
Page
of 12
Sort By:
Mayo Clinic Proceedings
|
August 1, 1995
Hereditary neuropathy with liability to pressure palsies and inherited brachial plexus neuropathy--two genetically distinct disorders
A J Windebank, A Schenone, G W Dewald
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1992
Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma
D J Brat, A J Windebank, S Brimijoin
Biochemical and Biophysical Research Communications
|
June 9, 1997
1,25-dihydroxyvitamin D3 regulates the expression of N-myc, c-myc, protein kinase C, and transforming growth factor-beta2 in neuroblastoma cells
T D Veenstra, A J Windebank, R Kumar
Glia
|
June 26, 2001
Role of the extracellular matrix in myelination of peripheral nerve
J L Podratz, E Rodriguez, A J Windebank
Annals of Neurology
|
October 1, 1993
Long-term follow-up of 121 patients with benign fasciculations
M D Blexrud, A J Windebank, J R Daube
Annals of Neurology
|
August 1, 1994
Role of nerve growth factor in suramin neurotoxicity studied in vitro
J W Russell, A J Windebank, J L Podratz
Neuroscience Letters
|
July 11, 2001
Nerve growth factor rescue of cisplatin neurotoxicity is mediated through the high affinity receptor: studies in PC12 cells and p75 null mouse dorsal root ganglia
S J Fischer, J L Podratz, A J Windebank
Annals of the New York Academy of Sciences
|
May 25, 1995
Electrophysiologic changes in neuromuscular function over five years in polio survivors
J R Daube, A J Windebank, W J Litchy
Brain Research. Molecular Brain Research
|
January 1, 1992
P0 gene expression in Schwann cells is modulated by an increase of cAMP which is dependent on the presence of axons
A C LeBlanc, A J Windebank, J F Poduslo
Mayo Clinic Proceedings
|
June 1, 1995
Treatment of stable chronic demyelinating polyneuropathy with 3,4-diaminopyridine
J W Russell, A J Windebank, C M Harper
Page
of 12
Search research articles
Search
Showing results (31-40 of 118) with videos related to
Sort By:
Page
of 12
Mayo Clinic Proceedings
|
August 1, 1995
Hereditary neuropathy with liability to pressure palsies and inherited brachial plexus neuropathy--two genetically distinct disorders
A J Windebank, A Schenone, G W Dewald
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1992
Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma
D J Brat, A J Windebank, S Brimijoin
Biochemical and Biophysical Research Communications
|
June 9, 1997
1,25-dihydroxyvitamin D3 regulates the expression of N-myc, c-myc, protein kinase C, and transforming growth factor-beta2 in neuroblastoma cells
T D Veenstra, A J Windebank, R Kumar
Glia
|
June 26, 2001
Role of the extracellular matrix in myelination of peripheral nerve
J L Podratz, E Rodriguez, A J Windebank
Annals of Neurology
|
October 1, 1993
Long-term follow-up of 121 patients with benign fasciculations
M D Blexrud, A J Windebank, J R Daube
Annals of Neurology
|
August 1, 1994
Role of nerve growth factor in suramin neurotoxicity studied in vitro
J W Russell, A J Windebank, J L Podratz
Neuroscience Letters
|
July 11, 2001
Nerve growth factor rescue of cisplatin neurotoxicity is mediated through the high affinity receptor: studies in PC12 cells and p75 null mouse dorsal root ganglia
S J Fischer, J L Podratz, A J Windebank
Annals of the New York Academy of Sciences
|
May 25, 1995
Electrophysiologic changes in neuromuscular function over five years in polio survivors
J R Daube, A J Windebank, W J Litchy
Brain Research. Molecular Brain Research
|
January 1, 1992
P0 gene expression in Schwann cells is modulated by an increase of cAMP which is dependent on the presence of axons
A C LeBlanc, A J Windebank, J F Poduslo
Mayo Clinic Proceedings
|
June 1, 1995
Treatment of stable chronic demyelinating polyneuropathy with 3,4-diaminopyridine
J W Russell, A J Windebank, C M Harper
Page
of 12